• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析患者心血管疾病风险概况比较

Cardiovascular disease risk profiles comparison among dialysis patients.

作者信息

Sharabas Islam, Siddiqi Nauman

机构信息

Department of Nephrology, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia.

出版信息

Saudi J Kidney Dis Transpl. 2016 Jul-Aug;27(4):692-700. doi: 10.4103/1319-2442.185225.

DOI:10.4103/1319-2442.185225
PMID:27424685
Abstract

This study was performed to assess the cardiovascular disease (CVD) risk factors in the prevalent peritoneal dialysis (PD) and hemodialysis (HD) patients and their association with cardiovascular events (CVEs) in a Saudi end-stage renal disease cohort. This was a prospective, observational, single-center study. A total of 192 patients were screened of which 157 patients were eligible (HD = 121, PD = 36). All patients underwent assessment of cardiovascular risk factors at the time of enrollment including electrocardiogram and echocardiography, lipid profile, homocysteine, and insulin levels. Patients were followed for one year and CVE [acute myocardial infarction, cerebrovascular accident (CVA), and congestive heart failure] and mortality were recorded. SPSS ® Version 16 was used for the analysis. T-test and ANOVA were used for continuous data; categorical data were analyzed using Chi-square and Mann-Whitney tests. The primary end-point of CVE and all-cause mortality was compared in the two groups using Kaplan-Meier survival analysis. HD patients were older and had been longer on dialysis. While PD patients had higher urine output and better Kt/V values, they were more edematous and using more antihypertensive medications. PD patients also had a lower ejection fraction (EF). Age >57 years and the use of more than one antihypertensive medication were associated with higher risk of CVE, while EF >53 was found to be protective. Age >57 years and EF <53 at enrollment were predictive of all-cause mortality. Saudi patients undergoing PD have worse CVD risk profiles compared to HD patients. Age less than 57 years and an EF >53 were cardioprotective.

摘要

本研究旨在评估沙特终末期肾病队列中,腹膜透析(PD)和血液透析(HD)患者的心血管疾病(CVD)危险因素及其与心血管事件(CVE)的关联。这是一项前瞻性、观察性、单中心研究。共筛选了192例患者,其中157例符合条件(HD = 121例,PD = 36例)。所有患者在入组时均接受了心血管危险因素评估,包括心电图、超声心动图、血脂谱、同型半胱氨酸和胰岛素水平。对患者进行了一年的随访,并记录了CVE[急性心肌梗死、脑血管意外(CVA)和充血性心力衰竭]及死亡率。使用SPSS®16版进行分析。连续数据采用t检验和方差分析;分类数据采用卡方检验和曼-惠特尼检验进行分析。使用Kaplan-Meier生存分析比较两组的CVE和全因死亡率的主要终点。HD患者年龄较大,透析时间更长。虽然PD患者尿量较多且Kt/V值较好,但他们水肿更严重,使用的降压药物更多。PD患者的射血分数(EF)也较低。年龄>57岁和使用一种以上降压药物与CVE风险较高相关,而EF>53被发现具有保护作用。入组时年龄>57岁和EF<53可预测全因死亡率。与HD患者相比,接受PD治疗的沙特患者的CVD风险状况更差。年龄小于57岁和EF>53具有心脏保护作用。

相似文献

1
Cardiovascular disease risk profiles comparison among dialysis patients.透析患者心血管疾病风险概况比较
Saudi J Kidney Dis Transpl. 2016 Jul-Aug;27(4):692-700. doi: 10.4103/1319-2442.185225.
2
Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.血液透析和腹膜透析患者的透析方式与心血管死亡率比较
Adv Perit Dial. 2016;32:22-31.
3
Dialysis vintage and cardiovascular injury as factors influencing long-term survival in peritoneal dialysis and hemodialysis.透析龄和心血管损伤作为影响腹膜透析和血液透析长期生存的因素。
Adv Clin Exp Med. 2017 Mar-Apr;26(2):251-258. doi: 10.17219/acem/64936.
4
[Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].[近年来加那利群岛新入透析患者的中期生存分析:当前腹膜透析与血液透析的比较]
Nefrologia. 2011;31(2):174-84. doi: 10.3265/Nefrologia.pre2011.Jan.10743.
5
Comparison of the risk of de novo cardiovascular disease between hemodialysis and peritoneal dialysis in patients with end-stage renal disease.终末期肾病患者中血液透析与腹膜透析新发心血管疾病风险的比较。
Int J Cardiol. 2016 Sep 1;218:219-224. doi: 10.1016/j.ijcard.2016.05.036. Epub 2016 May 14.
6
Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure.终末期肾病合并充血性心力衰竭患者行血液透析相对腹膜透析的生存优势。
Kidney Int. 2011 Nov;80(9):970-977. doi: 10.1038/ki.2011.233. Epub 2011 Jul 20.
7
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
8
Risk Factors Affecting Graft and Patient Survivals After Transplantation From Deceased Donors in a Developing Country: A Single-Center Experience.发展中国家已故供体移植术后影响移植物和患者存活的危险因素:单中心经验
Transplant Proc. 2017 Mar;49(2):270-277. doi: 10.1016/j.transproceed.2016.12.009.
9
Association of sclerostin with cardiovascular events and mortality in dialysis patients.硬骨素与透析患者心血管事件和死亡的相关性。
Ren Fail. 2020 Nov;42(1):282-288. doi: 10.1080/0886022X.2020.1741386.
10
Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.矿物质代谢与心血管疾病发病率及死亡风险:腹膜透析患者与血液透析患者的比较
Nephrol Dial Transplant. 2006 Sep;21(9):2513-20. doi: 10.1093/ndt/gfl257. Epub 2006 Jun 24.

引用本文的文献

1
Findings of Cardiovascular Workup of Kidney Transplant Candidates: A Retrospective Study of a Single-Center in Saudi Arabia.肾移植候选者心血管检查结果:沙特阿拉伯单中心回顾性研究
Int J Nephrol. 2023 Oct 10;2023:4653069. doi: 10.1155/2023/4653069. eCollection 2023.
2
Risk Factors for Chronic Kidney Disease in Older Adults with Hyperlipidemia and/or Cardiovascular Diseases in Taipei City, Taiwan: A Community-Based Cross-Sectional Analysis.台湾台北市高血脂和/或心血管疾病老年患者慢性肾脏病的危险因素:一项基于社区的横断面分析。
Int J Environ Res Public Health. 2020 Nov 25;17(23):8763. doi: 10.3390/ijerph17238763.
3
Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis.
血液透析与腹膜透析患者心血管死亡率的比较。
Int Urol Nephrol. 2021 Jul;53(7):1363-1371. doi: 10.1007/s11255-020-02683-9. Epub 2020 Oct 28.
4
The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular Disease.高密度脂蛋白在慢性肾脏病患者中的作用和功能及心血管疾病风险。
Int J Mol Sci. 2020 Jan 17;21(2):601. doi: 10.3390/ijms21020601.
5
Hospitalization rate and outcomes in patients with left ventricular dysfunction receiving hemodialysis.接受血液透析的左心室功能不全患者的住院率及治疗结果
Int J Gen Med. 2018 Dec 6;11:463-472. doi: 10.2147/IJGM.S179206. eCollection 2018.
6
Cardiorenal Syndrome in Western Countries: Epidemiology, Diagnosis and Management Approaches.西方国家的心肾综合征:流行病学、诊断与管理方法
Kidney Dis (Basel). 2017 Jan;2(4):151-163. doi: 10.1159/000448749. Epub 2016 Sep 10.